I think I remember a question during a CC, shortly after the trial completed, posed to NP, which asked if the cd-10 participants had been told which arm of the trial they were in, to which he replied, "No". The follow up was when or if(don't remember if that was questioned exactly like that)and his reply was something like, "not sure" or "I don't think so". But how ever he replied it was clear that disclosure was 100% up to CytoDyn and only if and when they felt like it. Anybody that has a better recollection, feel free to correct.